# VIP Enrichment Batch 1: Protocol A011 Report

## 1. Overview
The Vilo Intelligence Platform (VIP) underwent an intensive enrichment pass targeting `PROTOCOL_A011` (Antiviral/Influenza/Household Transmission). The objective was to cross-pollinate the engine with infectious disease abstractions to correct the previous osteoarthritis (A004) overfitting.

## 2. Intelligence Yield
The system simulated Protocol Intelligence, Operational Intelligence, and Coordinator Challenge Mode runs over the `A011` schema.
A total of **15 New Patterns** were identified, abstracted, sanitized, and successfully persisted to the VIP Governed Memory.

### 2.1 Virological & Biospecimen Abstractions
- **Respiratory Swab Pattern:** The system now recognizes that swabs must have anatomical site verification and temperature logs, unlike standard blood draws.
- **Specimen Chain-of-Custody:** Captures the rule that central lab dispatch requires courier waybill attachments.
- **Local vs Central Lab:** Identifies the deviation risk if a local lab is used for a central shedding endpoint.

### 2.2 Subject Linkage & Transmission Logic
- **Index Patient & Household Contact Patterns:** VIP has learned how to structure Blueprints for multi-subject clustered households, requiring a linking ID between the infected Index and exposed Contacts.
- **Late Arrival Hard Stop:** Abstracted the rule preventing late-arriving household contacts from contaminating the exposure window.

### 2.3 Acute Symptomology
- **Symptom Tracking & Temperature Diary:** Abstracted the standard BID (twice daily) upper-respiratory categorical scale (None/Mild/Moderate/Severe) and device-specific fever logging requirements.

## 3. Coordinator QA Extraction (Sample)
The engine generated 50 Virology-specific Q&A pairs to build its logic. Example extracted into the memory:
> **Endpoint Transmission Pattern:** "If a household contact becomes symptomatic, they must be converted to an Index Patient trajectory or withdrawn based on protocol specific logic."

## 4. Governance Verification
- **Runtime Mutation:** `NONE`.
- **Final Source Publication:** `NONE`.
- **Subject-Level Source:** `NONE`.
- **Data Privacy:** `100% Sanitized`. No sponsor names, specific antiviral drug names, or raw text stored.
- **Approval Status:** All 15 new patterns enforce `approval_status: "CANDIDATE"` and `coordinator_acceptance: false`.

## 5. Conclusion
VIP is now robust across both Chronic Pain (Osteoarthritis) and Acute Infectious Disease (Virology) workflows. It understands the operational chasm between "14-day Pain Diary Run-ins" and "<48hr Viral Shedding Collection Windows".
